Xeptiva is a clinical-stage biotech company that develops therapeutic vaccines for chronic conditions in animals. Our mission is to improve the quality of life and extend the years of life of pets. With several products in the pipeline, our main focus right now is the development of a therapy for osteoarthritis chronic pain and another one for atopic dermatitis in dogs. Both products are currently undergoing pivotal clinical trials.